PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 83 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,320 | -98.7% | 26,100 | -92.6% | 0.00% | -100.0% |
| Q1 2023 | $342,072 | -4.4% | 350,484 | +1.9% | 0.01% | -15.4% |
| Q4 2022 | $357,691 | -1.5% | 343,934 | +9.0% | 0.01% | -7.1% |
| Q3 2022 | $363,000 | -38.5% | 315,634 | +0.1% | 0.01% | -33.3% |
| Q2 2022 | $590,000 | -46.0% | 315,384 | -12.6% | 0.02% | -36.4% |
| Q1 2022 | $1,093,000 | -19.5% | 360,834 | +0.4% | 0.03% | -13.2% |
| Q4 2021 | $1,358,000 | -27.9% | 359,234 | -1.4% | 0.04% | -33.3% |
| Q3 2021 | $1,884,000 | +36.7% | 364,484 | +1.3% | 0.06% | +39.0% |
| Q2 2021 | $1,378,000 | +127.8% | 359,800 | +52.7% | 0.04% | +115.8% |
| Q1 2021 | $605,000 | +4.3% | 235,600 | +1.6% | 0.02% | -5.0% |
| Q4 2020 | $580,000 | +26.9% | 231,900 | +4.9% | 0.02% | +11.1% |
| Q3 2020 | $457,000 | -18.8% | 221,000 | +21.8% | 0.02% | -28.0% |
| Q2 2020 | $563,000 | +160.6% | 181,500 | +91.6% | 0.02% | +92.3% |
| Q1 2020 | $216,000 | – | 94,750 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 3,196,527 | $16,526,000 | 3.00% |
| BVF INC/IL | 5,328,239 | $27,547,000 | 1.08% |
| Soleus Capital Management, L.P. | 740,000 | $3,826,000 | 0.60% |
| Cutter & CO Brokerage, Inc. | 326,100 | $1,686,000 | 0.40% |
| EAM Investors, LLC | 288,459 | $1,491,000 | 0.25% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $5,316,000 | 0.15% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,551,000 | 0.11% |
| Navis Wealth Advisors, LLC | 16,000 | $83,000 | 0.06% |
| Sigma Planning Corp | 364,484 | $1,884,000 | 0.06% |
| XTX Topco Ltd | 32,650 | $169,000 | 0.06% |